Comparative effects of indomethacin and nabumetone on urine and electrolyte output in conscious rats

Journal of Pharmacological Sciences

Volumn 99, Issue 3, 2005, Pages 272-276

  Bin Long, Idris ^a   Singh, Harbindar Jeet ^a   Rao, Gurubelli Janardhana ^a  

^a SCHOOL OF MEDICAL SCIENCES   (Malaysia)

Author keywords

Conscious rat; Indomethacin; Nabumetone; Renal function

Indexed keywords

INDOMETACIN; NABUMETONE;

ANALYSIS OF VARIANCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CALCIUM EXCRETION; CONTROLLED STUDY; DATA ANALYSIS; DRUG URINE LEVEL; ELECTROLYTE EXCRETION; FLUID INTAKE; MAGNESIUM EXCRETION; MALE; NONHUMAN; RAT; SODIUM EXCRETION; URINE VOLUME;

EID: 28044455216     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.FPJ05008X     Document Type: Article

References (28)

1. Abramson S, Weissmann G. The mechanisms of action of nonsteroidal anti-inflammatory drugs. Arthritis Rheum. 1989;32:1-9.
2. Masferrer JL, Zweifel BS, Seibert K, Needleman P. Selective regulation of cellular cyclooxygenase by dexamethasone and endotoxin in mice. J Clin Invest. 1990;86:1375-1379.
3. Marnett LJ, Rowlinson SW, Goodwin DC, Kalgutkar AS, Lanzo CA. Arachidonic acid oxygenation by Cox-1 and Cox-2. J Biol Chem. 1999;274:22903-22906.
4. Patrono C, Dunn MJ. The clinical significance of inhibition of renal prostaglandin synthesis. Kidney Int. 1987;32:1-2.
5. Meade EA, Smith WL, Dewitt DL. Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isoenzyme by aspirin and other nonsteroidal anti-inflammatory drugs. J Biol Chem. 1993;268:6610-6614.
6. Harris RC, McKanna JA, Akai Y, Jacobson HR, Dubois RN, Breyer MD. Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction. J Clin Invest. 1994;94:2504-2510.
7. Traynor TR, Smart A, Briggs JP, Schnermann J. Inhibition of macula densa-stimulated renin secretion by pharmacological blockade of cyclooxygenase-2. Am J Physiol. 1999;277:F706-F710.
8. Breyer MD, Harris RC. Cyclooxygenase 2 and the kidney. Curr Opin Nephrol Hypertens. 2001;10:89-98.
9. Siegle I, Klein T, Bakman JT. Expression of Cox-1 and Cox-2 in human synovial tissue: differential elevation of COX-2 in inflammatory joint disease. Arthritis Rheum. 1998;41:122-129.
10. Gretzer B. Effects of diclofenac and L-745337, a selective cyclooxygenase-2 inhibitor, on prostaglandin E2 formation in tissue from human colonic mucosa and chronic bursitis. Gastroenterology. 1998;114:A139.
11. Clive DM, Stoff JS. Renal syndromes associated with nonsteroidal anti-inflammatory drugs. N Engl J Med. 1984;310:563-557.
12. Schlegel SI. General characteristics of nonsteriodal anti-inflammatory drugs. In: Drugs for rheumatic disease. Paulus HE, Furst DE, Dromgoole SH, editors. New York: Churchill Livingstone; 1987. p. 203-204.
13. Gomaa AA, Hassan HA, Ghanimah SA. Effect of aspirin and indomethacin on the serum and urinary calcium, magnesium and phosphate. Pharmacol Res. 1990;22:59-70.
14. Cook ME, Wallin JD, Thakur VD, Kadowitz PJ, McNamara DB, Garcia MM, et al. Comparative effects of nabumetone, sulinac, and ibuprofen on renal function. J Rheumatol. 1997;24:1137-1144.
15. Giannessi D, Lazzerini G, Filipponi P, Mannarelli C, Vaiani G, Grossi E, et al. Effects of nabumetone, a new non-steeriodal antiinflammatory drug, on urinary prostaglandin excretion in man. Pharmacol Res. 1993;28:229-242.
16. Freed M, Audet P, Zariffa N, Krishna G, Ilson B, Everitt D, et al. Comparative effects of nabumetone, sulindac, and indomethacin on urinary prostaglandin excretion and platelet function in volunteers. J Clin Pharmacol. 1994;34:1098-1108.
17. Asfawati, Singh HJ, Zalina I, Asiah AB, Salleh M, Ahmad A. Naprosyn increases urine output and microalbuminuria in conscious rats. Asia Pac J Phamacol. 2001;15 Suppl 2:S84.
18. Haylor J, Lote CJ. Renal function in conscious rats after indomethacin. Evidence for a tubular action of endogenous prostaglandins. J Physiol. 1980;298:371-381.
19. Cox PG, Moons MM, Russel FG, van Ginneken CA. Indometacin: renal handling and effects in the isolated perfused rat kidney. Pharmacology. 1991;42:287-296.
20. Breyer MD, Zhang Y, Guan YF, Hao CM, Hebert RL, Breyer RM. Regulation of renal function by prostaglandin E receptors. Kidney Int Suppl. 1998;67:S88-S94.
21. Stokes JB. Effect of prostaglandin E2 on chloride transport across the rabbit thick ascending limb of Henle. J Clin Invest. 1979;64:495-502.
22. Herbert RL, Jacobson HR, Fredin D, Breyer MD. Evidence that separate PGE2 receptors modulate water and sodium transport in rabbit corticol collecting duct. Am J Physiol. 1993;265:F643-F650.
23. Stokes JB, Kokko JP. Inhibition of sodium transport by prostaglandin E2 across the isolated perfused rabbit collecting tubule. J Clin Invest. 1977;52:1099-1104.
24. Friedlander G, Amiel C. Decreased calcium and magnesium urinary excretion during prostglandin synthesis inhibition in the rat. Prostaglandins. 1985;29:123-132.
25. Breyer MD, Breyer RM. Prostaglandin E receptors and the kidney. Am J Physiol Renal Physiol. 2000;279:F12-F23.
26. Yang T, Schermann JB, Briggs JP. Regulation of cyclooxygenase-2 expression in renal medulla by tonicity in vivo and in vitro. Am J Physiol. 1999;277:F1-F9.
27. Hao CM, Yull F, Blackwell T, Komhoff M, Davis LS, Breyer MD. Dehydration activates an NF-kappaB-driven, COX2-dependent survival mechanism in renal medullary interstitial cells. J Clin Invest. 2000;106:973-982.
28. Therland KL, Stubbe J, Thiesson HC, Ottosen PD, Walter S, Sorensen GL, et al. Cycloxygenase-2 is expressed in vasculature of normal and ischaemic adult human kidney and is colocalized with vascular prostaglandin E2 EP4 receptors. J Am Soc Nephrol. 2004;15:1189-1198.